相关实验视频
Updated: Mar 4, 2026

05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
2.2K
增强多佩里溶解的双重策略:机械化学合成的多成分盐在口腔可分散的片中
Kassius de Souza Reis1, Bruno Arantes Borges1, Ana Carolina Marioto Santos1
1Faculty of Pharmaceutical Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, 37130-001, Brazil.
Journal of pharmaceutical sciences
|March 2, 2026
概括
这项研究开发了多佩里 (DOM) 的新型固体形式,以改善口服吸收. 含有单化DOM糖酸盐的口腔可分解片显示了增强的溶解,可能导致更快的治疗效果.
科学领域:
- 制药科学 制药科学
- 固态化学 固态化学
- 药物输送系统 药物输送系统
背景情况:
- 佩里 (DOM) 是一种原动力学和抗药物,由于水溶性差和肠道新陈代谢,其生物利用性有限.
- 现有的配方在实现最佳治疗疗效方面面临着挑战,例如对胃衰竭和恶心等疾病的治疗.
研究的目的:
- 通过开发多组分固体形式,提高多佩里 (DOM) 的可溶性和生物利用性.
- 将这些新型固体形式纳入口腔可分散片 (ODT) 中,以改善药物吸收和更快的治疗结果.
主要方法:
- 使用水辅助机械化学合成,生产无水DOM DL-曼德拉酸和单水DOM糖酸.
- 固体形式使用PXRD,DSC,TGA和FTIR进行了表征.
- 制定了口腔可分散片 (ODT),并使用HPLC评估了它们的溶解性能.
主要成果:
- 与单一的DOM或DOM DL-曼德拉酸盐相比,单一的DOM糖酸盐的溶解率显著提高.
- ODT促进了这种剂型特征的快速分解.
- 增强溶解和快速分解的组合表明DOM吸收得到了改善.
结论:
- 多组分固体形式,特别是单化DOM糖酸盐,有效地改善了多佩里的溶解.
- 将其纳入ODT提供了一个有希望的策略,以提高DOM生物可用性并加速治疗结果.
- 这种方法有可能更快,更有效地治疗DOM指示的疾病.
相关概念视频
Drug Delivery Systems: Different Types
118
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
118
Factors Influencing Drug Absorption: Pharmaceutical Parameters
671
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
671
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
800
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
800
Oral Drug Delivery Systems: Introduction
93
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
93
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.8K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.8K
Oral Drug Delivery Systems: Continuous-Release Systems
88
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
88

